Eric Zhang
Chief Executive Officer at AKSO Biopharmaceutical, Inc.
Net worth: 174 010 $ as of 2023-12-30
Eric Zhang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AKSO Biopharmaceutical, Inc. | Chief Executive Officer | - | - |
| Founder | - | - |
Career history of Eric Zhang
Former positions of Eric Zhang
| Companies | Position | Start | End |
|---|---|---|---|
| ARAVIVE, INC. | Director/Board Member | 2018-10-11 | 2023-10-01 |
| Independent Dir/Board Member | 2018-10-11 | 2023-10-01 | |
Aravive Biologics, Inc.
 Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Director/Board Member | 2016-05-31 | 2018-09-30 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Director/Board Member | 2018-10-11 | - |
Training of Eric Zhang
| Queen's University | Undergraduate Degree |
Statistics
International
| United States | 5 |
| Canada | 2 |
Operational
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ARAVIVE, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Health Technology |
| AKSO Biopharmaceutical, Inc. |
- Stock Market
- Insiders
- Eric Zhang
- Experience
